Teva Pharmaceutical Industries Ltd (TEVA)
13.01
0.00 (0.00%)
USD |
NYSE |
Apr 24, 16:00
12.85
-0.16
(-1.23%)
After-Hours: 20:00
Teva Pharmaceutical Industries Cash and Short Term Investments (Quarterly): 3.226B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.226B |
| September 30, 2023 | 2.249B |
| June 30, 2023 | 2.669B |
| March 31, 2023 | 2.143B |
| December 31, 2022 | 2.801B |
| September 30, 2022 | 2.225B |
| June 30, 2022 | 2.058B |
| March 31, 2022 | 2.175B |
| December 31, 2021 | 2.165B |
| September 30, 2021 | 2.045B |
| June 30, 2021 | 2.436B |
| March 31, 2021 | 1.743B |
| December 31, 2020 | 2.177B |
| September 30, 2020 | 1.827B |
| June 30, 2020 | 2.402B |
| March 31, 2020 | 1.804B |
| December 31, 2019 | 1.975B |
| September 30, 2019 | 1.241B |
| June 30, 2019 | 2.165B |
| March 31, 2019 | 1.973B |
| December 31, 2018 | 1.782B |
| September 30, 2018 | 1.875B |
| June 30, 2018 | 1.861B |
| March 31, 2018 | 1.418B |
| December 31, 2017 | 963.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 680.00M |
| June 30, 2017 | 599.00M |
| March 31, 2017 | 900.00M |
| December 31, 2016 | 988.00M |
| September 30, 2016 | 1.557B |
| June 30, 2016 | 6.984B |
| March 31, 2016 | 5.964B |
| December 31, 2015 | 6.946B |
| September 30, 2015 | 928.00M |
| June 30, 2015 | 1.068B |
| March 31, 2015 | 3.396B |
| December 31, 2014 | 2.226B |
| September 30, 2014 | 1.473B |
| June 30, 2014 | 949.00M |
| March 31, 2014 | 901.00M |
| December 31, 2013 | 1.038B |
| September 30, 2013 | 1.148B |
| June 30, 2013 | 1.245B |
| March 31, 2013 | 1.394B |
| December 31, 2012 | 2.879B |
| September 30, 2012 | 1.432B |
| June 30, 2012 | 1.188B |
| March 31, 2012 | 1.062B |
| December 31, 2011 | 1.096B |
| September 30, 2011 | 1.123B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.241B
Minimum
Sep 2019
3.226B
Maximum
Dec 2023
2.186B
Average
2.165B
Median
Jun 2019
Cash and Short Term Investments (Quarterly) Benchmarks
| Viatris Inc | 1.184B |
| Alvotech | 11.16M |
| Johnson & Johnson | 22.93B |
| AbbVie Inc | 12.82B |
| Novartis AG | 13.96B |